D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 116 Citations 51,147 432 World Ranking 1851 National Ranking 1083

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Surgery

His primary areas of study are Melanoma, Surgery, Sentinel lymph node, Lymph node and Internal medicine. His research in Melanoma is mostly concerned with Cutaneous melanoma. The concepts of his Surgery study are interwoven with issues in Cancer and Breast cancer.

The concepts of his Sentinel lymph node study are interwoven with issues in Lymphovascular invasion, Metastasis, Lymph and Biopsy, Radiology. Merrick I. Ross has included themes like Wide local excision, Predictive value of tests, Nuclear medicine, Lymphatic system and Dissection in his Lymph node study. Merrick I. Ross has researched Internal medicine in several fields, including Gastroenterology and Oncology.

His most cited work include:

  • Final Version of 2009 AJCC Melanoma Staging and Classification (3479 citations)
  • Genomic Classification of Cutaneous Melanoma (1491 citations)
  • Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma (1183 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Melanoma, Surgery, Internal medicine, Oncology and Sentinel lymph node. His Melanoma research is multidisciplinary, incorporating elements of Stage, Radiology and Lymph node, Pathology. His research in Surgery intersects with topics in Cancer, Breast cancer and Lymphadenectomy.

When carried out as part of a general Internal medicine research project, his work on Surgical oncology, Primary tumor and Clinical trial is frequently linked to work in In patient, therefore connecting diverse disciplines of study. His research investigates the link between Oncology and topics such as Ipilimumab that cross with problems in Phases of clinical research. His research investigates the connection between Sentinel lymph node and topics such as Biopsy that intersect with issues in Sentinel node and Lymphatic mapping.

He most often published in these fields:

  • Melanoma (49.80%)
  • Surgery (38.82%)
  • Internal medicine (37.20%)

What were the highlights of his more recent work (between 2015-2021)?

  • Internal medicine (37.20%)
  • Melanoma (49.80%)
  • Oncology (32.52%)

In recent papers he was focusing on the following fields of study:

Merrick I. Ross mainly investigates Internal medicine, Melanoma, Oncology, Talimogene laherparepvec and Phases of clinical research. Merrick I. Ross merges many fields, such as Internal medicine and In patient, in his writings. His Melanoma study incorporates themes from Stage, Sentinel lymph node, Targeted therapy and Lymph node.

Merrick I. Ross interconnects Biopsy and Radiology in the investigation of issues within Sentinel lymph node. Merrick I. Ross focuses mostly in the field of Lymph node, narrowing it down to matters related to Dissection and, in some cases, Metastasis. His Oncology study combines topics in areas such as Cancer, Adjuvant therapy, Primary tumor and Cutaneous melanoma.

Between 2015 and 2021, his most popular works were:

  • Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma (272 citations)
  • Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma (257 citations)
  • Melanoma, version 2.2016 clinical practice guidelines in oncology (155 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Surgery

His primary scientific interests are in Internal medicine, Oncology, Melanoma, Talimogene laherparepvec and Phases of clinical research. Metastatic melanoma is closely connected to Immunology in his research, which is encompassed under the umbrella topic of Internal medicine. In the field of Oncology, his study on Adjuvant overlaps with subjects such as Clinical Practice.

His study in Melanoma is interdisciplinary in nature, drawing from both Stage, Surgery, Biopsy and Gastroenterology. His study connects Sentinel lymph node and Biopsy. His work carried out in the field of Cutaneous melanoma brings together such families of science as Interferon alfa and Lymph node.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Final Version of 2009 AJCC Melanoma Staging and Classification

Charles M. Balch;Jeffrey E. Gershenwald;Seng Jaw Soong;John F. Thompson.
Journal of Clinical Oncology (2009)

4876 Citations

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

Robert H.I. Andtbacka;Howard L. Kaufman;Frances Collichio;Thomas Amatruda.
Journal of Clinical Oncology (2015)

1672 Citations

Genomic Classification of Cutaneous Melanoma

Rehan Akbani;Kadir C. Akdemir;B. Arman Aksoy;Monique Albert.
Cell (2015)

1552 Citations

Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy

Henry M. Kuerer;Lisa A. Newman;Terry L. Smith;Fred C. Ames.
Journal of Clinical Oncology (1999)

1455 Citations

Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients.

Jeffrey E. Gershenwald;William Thompson;Paul F. Mansfield;Jeffrey E. Lee.
Journal of Clinical Oncology (1999)

1366 Citations

The orderly progression of melanoma nodal metastases.

Douglas Reintgen;C. Cruse;Karen Wells;Claudia Berman.
Annals of Surgery (1994)

886 Citations

Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger.

Charles M. Balch;Seng Jaw Soong;Alfred A. Bartolucci;Marshall M. Urist.
Annals of Surgery (1996)

792 Citations

Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma

John Albertini;C. Cruse;David Rapaport;Karen Wells.
Annals of Surgery (1996)

704 Citations

Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma.

Jeffrey E. Gershenwald;Maria I. Colome;Jeffrey E. Lee;Paul F. Mansfield.
Journal of Clinical Oncology (1998)

616 Citations

Long-Term Results of a Multi-Institutional Randomized Trial Comparing Prognostic Factors and Surgical Results for Intermediate Thickness Melanomas (1.0 to 4.0 mm)

Charles M. Balch;Seng Jaw Soong;Merrick I. Ross;Marshall M. Urist.
Annals of Surgical Oncology (2000)

573 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Merrick I. Ross

John F. Thompson

John F. Thompson

University of Sydney

Publications: 399

Richard A. Scolyer

Richard A. Scolyer

Royal Prince Alfred Hospital

Publications: 319

Dirk Schadendorf

Dirk Schadendorf

University of Duisburg-Essen

Publications: 176

Alexander M.M. Eggermont

Alexander M.M. Eggermont

Erasmus University Rotterdam

Publications: 162

Claus Garbe

Claus Garbe

University of Tübingen

Publications: 159

Vernon K. Sondak

Vernon K. Sondak

University of South Florida

Publications: 156

Georgina V. Long

Georgina V. Long

University of Sydney

Publications: 137

Henry Mark Kuerer

Henry Mark Kuerer

The University of Texas MD Anderson Cancer Center

Publications: 131

Kelly K. Hunt

Kelly K. Hunt

The University of Texas MD Anderson Cancer Center

Publications: 120

Paolo A. Ascierto

Paolo A. Ascierto

National Institutes of Health

Publications: 113

Reinhard Dummer

Reinhard Dummer

University of Zurich

Publications: 110

Kelly M. McMasters

Kelly M. McMasters

University of Louisville

Publications: 108

John M. Kirkwood

John M. Kirkwood

University of Pittsburgh

Publications: 107

Jeffrey E. Gershenwald

Jeffrey E. Gershenwald

The University of Texas MD Anderson Cancer Center

Publications: 100

Gabriel N. Hortobagyi

Gabriel N. Hortobagyi

The University of Texas MD Anderson Cancer Center

Publications: 95

Elizabeth A. Mittendorf

Elizabeth A. Mittendorf

Brigham and Women's Hospital

Publications: 92

Trending Scientists

Mario Forni

Mario Forni

University of Modena and Reggio Emilia

Nils Henrik Risebro

Nils Henrik Risebro

University of Oslo

David F. Sorrells

David F. Sorrells

ParkerVision

Yu Lei

Yu Lei

Sun Yat-sen University

Manuel Prieto

Manuel Prieto

Instituto Superior Técnico

Andrew S. Kende

Andrew S. Kende

University of Rochester

Liangbin Li

Liangbin Li

University of Science and Technology of China

D. Amaranatha Reddy

D. Amaranatha Reddy

Indian Institute of Information Technology, Design & Manufacturing, Kurnool

Niels C. Bols

Niels C. Bols

University of Waterloo

Kenji Ishii

Kenji Ishii

Nippon Medical School

Gilles E. Gignac

Gilles E. Gignac

University of Western Australia

Jennifer H. Pfeifer

Jennifer H. Pfeifer

University of Oregon

Adamson S. Muula

Adamson S. Muula

University of Malawi

Michael A. Morrisey

Michael A. Morrisey

Texas A&M University

Marlène Laruelle

Marlène Laruelle

George Washington University

Eugene McLaughlin

Eugene McLaughlin

City, University of London

Something went wrong. Please try again later.